UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance

British journal of cancer, 2021-03, Vol.124 (7), p.1237-1248

2021

Volltextzugriff (PDF)

A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma

Thoracic cancer, 2024-02, Vol.15 (5), p.427-433

2024

Volltextzugriff (PDF)

Study on Bending Beam Delayed Cracking of Ultra High-strength DP Steel for Automotive Use

Journal of physics. Conference series, 2021-05, Vol.1906 (1), p.12003

2021

Volltextzugriff (PDF)

Welding procedure qualification of Q345 grade fire-resistant steel based on Jmat-pro calculation

Journal of physics. Conference series, 2021-04, Vol.1903 (1), p.12001

2021

Volltextzugriff (PDF)

Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study

Thoracic cancer, 2023-11, Vol.14 (31), p.3147-3160

2023

Volltextzugriff (PDF)

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report

Thoracic cancer, 2022-02, Vol.13 (3), p.497-501

2022

Volltextzugriff (PDF)

Compromise or not? A case report of successful treatment of pembrolizumab‐induced hepatitis in a patient with non‐small cell lung cancer with low‐dose methylprednisolone and bicyclol

Thoracic cancer, 2020-07, Vol.11 (7), p.2023-2030

2020

Volltextzugriff (PDF)

The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions

Current research in pharmacology and drug discovery, 2021-01, Vol.2, p.100028-100028, Article 100028

2021

Volltextzugriff (PDF)

Safety and efficacy evaluation of personalized exercise prescription during chemotherapy for lung cancer patients

Thoracic cancer, 2024-04, Vol.15 (11), p.906-918

2024

Volltextzugriff (PDF)

Effects of Isothermal Temperature on Microstructure and Properties for N80 Oil Pipe Steel

Journal of physics. Conference series, 2021-08, Vol.1986 (1), p.12019

2021

Volltextzugriff (PDF)

Study on Salt Spray Delayed Cracking Performance of Ultra-high Strength Martensitic Steel

IOP conference series. Earth and environmental science, 2021-05, Vol.768 (1), p.12025

2021

Volltextzugriff (PDF)

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data

Signal transduction and targeted therapy, 2024-08, Vol.9 (1), p.222-12

2024

Volltextzugriff (PDF)

Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study

Thoracic cancer, 2022-06, Vol.13 (11), p.1684-1690

2022

Volltextzugriff (PDF)

Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Thoracic cancer, 2021-12, Vol.12 (23), p.3157-3168

2021

Volltextzugriff (PDF)

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Thoracic cancer, 2021-04, Vol.12 (7), p.997-1005

2021

Volltextzugriff (PDF)

Abstract 422: Sequential targeted therapy and immunotherapy of a BRAF positive metastatic melanoma patient with BRAF inhibitor vemurafenib, MEK inhibitor cobimetnib and a novel PD-1 antibody Sintilimab

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.422-422

2021

Volltextzugriff (PDF)

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC

The New England journal of medicine, 2023-11, Vol.389 (21), p.1935-1948

2023

Volltextzugriff (PDF)

SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells

Molecular carcinogenesis, 2024-04, Vol.63 (4), p.742-756

2024

Volltextzugriff (PDF)

Abstract 4795: Nrf2 protects against chemotherapy-induced steatohepatitis and peripheral neurotoxicity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4795-4795

2017

Volltextzugriff (PDF)

Combination of antibody-coated, physical-based microfluidic chip with wave-shaped arrays for isolating circulating tumor cells

Biomedical microdevices, 2017-09, Vol.19 (3), p.66-66, Article 66

2017

Volltextzugriff (PDF)

Influence of Blade Wrap Angle on Centrifugal Pump Performance by Numerical and Experimental Study

Chinese journal of mechanical engineering, 2014, Vol.27 (1), p.171-177

English ed., 2014

Volltextzugriff (PDF)

Dilemma and solutions of treatment delay in cancer patients during the COVID‐19 pandemic: A single‐center, prospective survey

Asia-Pacific journal of clinical oncology, 2022-10, Vol.18 (5), p.e338-e345

2022

Volltextzugriff (PDF)

EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20529-e20529

2017

Volltextzugriff (PDF)

Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

Cancer Immunology, Immunotherapy : CII, 2024-07, Vol.73 (9), p.182, Article 182

2024

Volltextzugriff (PDF)

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

The lancet respiratory medicine, 2024-08, Vol.12 (8), p.589-598

2024

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Aktive Filter

KollektionIngenta E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(164)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(55)
Technology
(55)
Physical Sciences
(44)
Science & Technology - Other Topics
(40)
Chemistry
(38)
Nanoscience & Nanotechnology
(32)
Chemistry, Multidisciplinary
(29)
Engineering
(26)
Materials Science
(25)
Materials Science, Multidisciplinary
(25)
Humans
(22)
Environmental Sciences
(21)
Chemistry, Physical
(20)
Environmental Sciences & Ecology
(20)
Oncology
(20)
Physics
(17)
Lung Cancer
(14)
Nanoparticles
(13)
Respiratory System
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Acs Nano
(17)
Thoracic Cancer
(12)
Environmental Science & Technology
(10)
Environmental Science. Nano
(8)
Nanoscale
(5)
Small
(5)
Analytical Methods
(3)
Cancer Research
(3)
Journal Of Energy Storage
(3)
Journal Of Physics. Conference Series
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance

A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma

Study on Bending Beam Delayed Cracking of Ultra High-strength DP Steel for Automotive Use

Welding procedure qualification of Q345 grade fire-resistant steel based on Jmat-pro calculation

Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report

Compromise or not? A case report of successful treatment of pembrolizumab‐induced hepatitis in a patient with non‐small cell lung cancer with low‐dose methylprednisolone and bicyclol

The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions

Safety and efficacy evaluation of personalized exercise prescription during chemotherapy for lung cancer patients

Effects of Isothermal Temperature on Microstructure and Properties for N80 Oil Pipe Steel

Study on Salt Spray Delayed Cracking Performance of Ultra-high Strength Martensitic Steel

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data

Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study

Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Abstract 422: Sequential targeted therapy and immunotherapy of a BRAF positive metastatic melanoma patient with BRAF inhibitor vemurafenib, MEK inhibitor cobimetnib and a novel PD-1 antibody Sintilimab

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC

SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells

Abstract 4795: Nrf2 protects against chemotherapy-induced steatohepatitis and peripheral neurotoxicity

Combination of antibody-coated, physical-based microfluidic chip with wave-shaped arrays for isolating circulating tumor cells

Influence of Blade Wrap Angle on Centrifugal Pump Performance by Numerical and Experimental Study

Dilemma and solutions of treatment delay in cancer patients during the COVID‐19 pandemic: A single‐center, prospective survey

EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance

Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

Aktive Filter

Suchergebnisse filtern